Silvia Bertagnolio, Olga Tosas, Kitty Van Weezenbeek and Amitabh Suthar discuss surveillance of #AntimicrobialResistance, the existing limitations and the implications this has on accurate determination of incidence: https://t.co/QExxV6AZ9Z @amitabhsuthar@WHO#AMR#GlobalHealth
New report discusses ways CDC enhanced existing data surveillance system to more quickly count #COVID19 case & death data during the pandemic.
Read more for lessons learned & how this surveillance system could help speed detection in future outbreaks. https://t.co/fZKBVmXlh2
Dr Amitabh Suthar and Dr Christopher Dye give their perspective on infection, immunity and surveillance of COVID-19. https://t.co/i2rKf6w0EM #COVID19#pandemic#PublicHealth#GlobalHealth
Public health impact of #covid19#vaccines in the US: observational study - 10% increase in vaccination coverage was associated with 8% reduction in mortality and 7% reduction nin incidence. https://t.co/7kEDjiF0aw via @AmitabhSuthar and colleagues, @bmj_latest
Public health impact of #COVID19 vaccines in the US: observational study @AmitabhSuthar@bmj_latest
➡️Conclusions
➡️Higher vaccination coverage was associated with lower rates of population level covid-19 mortality and incidence in the US
https://t.co/xUY8v3LGbs
Paper and accompanying editorial
https://t.co/uwqY0PqYsE
"Many more lives could have been saved......
this new study is another confidence booster for covid-19 vaccines."
Analysis of over 30 million US Covid cases and 440,00 deaths in >2500 counties: For every 10% improvement in vaccination coverage *per county*, there was an 8% reduction in mortality
https://t.co/Vpfdhs5iYA
🆕 @bmj_latest documenting the community level benefit vs severe disease
Impressive positive impact of COVID vaccination at a population level:
"A 10% improvement in vaccination coverage was associated with an 8% reduction in mortality rates..."
https://t.co/mU1BRjsV1Y by @AmitabhSuthar et al.
US mortality data indicate that #COVID19 was the third leading cause of death https://t.co/6oJMgzRdky These data do not include excess deaths from other conditons related to lack of hospital beds and/or mitigation measures. These may increase estimates 3x https://t.co/znJcVnm0Ag
JID: Analysis of 50 studies and nearly 2 million individuals suggest that ~43% of COVID infections experience post COVID conditions. Problems with sleep, memory, concentration, anxiety, and depression were amongst the most common
https://t.co/otgDRsksZY
Great to see our community lookback study picked up in this @CDCgov opinion piece from @AmitabhSuthar ‘Coronavirus Disease Case Definitions, Diagnostic Testing Criteria, and Surveillance in 25 Countries with Highest Reported Case Counts‘ https://t.co/V6B4yvaKfH
@doctorsoumya Agreed! I am worried that in some places the adverse effects on other essential health services may be worse than COVID itself if innovative service delivery models aren't implemented
CID: 8% of #COVID19 patients had a bacterial/fungal infection during hospitalisation. 72% receiving broadspectrum antibiotics. Urgent need for guidance to ensure appropriate antimicrobial use during the pandemic @hygetahun@gardp_amr@IDSAInfo@NICEComms
https://t.co/7MvQpEX5zu
Countries are receiving fast track support to help in the fight against #Coronavirus. @WorldBank Group is prepared to deploy up to $160 billion over the next 15 months. https://t.co/w8RJs3X6uj #COVID19
Useful insights from @MOFAVietNam on their #COVID19 response. Primed by SARS, Viet Nam was swift in introducing:
(1) systematic screening of individuals at borders (hospitalising symptomatic and quarantining asymptomatic for 14 days)
(2) aggressive contact tracing and isolation